Skip to main content
. Author manuscript; available in PMC: 2017 Sep 29.
Published in final edited form as: Bone Marrow Transplant. 2013 Oct 28;49(2):248–253. doi: 10.1038/bmt.2013.167

Figure 3.

Figure 3

OS and PFS. (a) TAC/μMTX/MMF results in significantly better OS than TAC/MMF. (b) There is a trend toward improved PFS for TAC/μMTX/MMF when compared to TAC/MMF. Abbreviations: μMTX = micro-dose MTX (7.5 mg/m2); MMF = mycophenolate mofetil; MTX = standard-dose MTX (30–40 mg/m2); TAC = tacrolimus.